Meta AnalysisID 7631
发展中国家非转移性乳腺癌女性内分泌治疗的依从率、副作用及临床结局：系统评价与Meta分析
CRD42023490977
• What is the overall rate of adherence to endocrine therapies among women with non-metastatic breast cancer in developing countries? • What is the rate of frequent side effects of endocrine therapies among women with no
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7631
- Evidence Id
- 16189
- Core Evidence Id
- 16189
- Source Meta Analysis Id
- 7625
- Herb2 Meta Analysis Id
- HBMA007625
- Crd Id
- CRD42023490977
- Title
- Rate of adherence, side effects and clinical outcomes of endocrine therapies among women with non-metastatic breast cancer in developing countries: a systematic review and meta-analysis
- Review Question
- • What is the overall rate of adherence to endocrine therapies among women with non-metastatic breast cancer in developing countries? • What is the rate of frequent side effects of endocrine therapies among women with non-metastatic breast cancer in developing countries? • What is the rate of disease recurrence and death among women with non-metastatic breast cancer treated with endocrine therapies in developing countries?
- Study Type Included
- Include: peer-reviewed, observational studies that report at least one of the outcomes of interest Exclude: clinical trials, case reports, case series, reviews, commentaries, editorials, and meeting abstracts
- Condition Being Studied
- Breast cancer without metastasis
- Participant
- Women with non-metastatic breast cancer diagnosis in a developing country
- Animal
- Human Disease Modelled
- Intervention
- Oral endocrine medication regimen including: tamoxifen and aromatase inhibitors (anastrozole, letrozole or exemestane)
- Comparator Control
- Not applicable
- Main Outcome
- • Rate of adherence including (initiation, daily adherence, or persistence over time) • Rate of most commonly reported adverse events • Rate of disease recurrence or death Measures of effect Rate
- Outcome Measure
- Additional Outcome
- Study Method
- Meta-analysis, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Shaimaa Elshafie [email protected]
- Organisational Affiliation
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- Country
- United States of America
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-12-07
- Registration Date
- 2023-12-18
- Anticipated Start Date
- 2023-07-01
- Anticipated Completion Date
- 2024-07-01
- Title Cn
- 发展中国家非转移性乳腺癌女性内分泌治疗的依从率、副作用及临床结局：系统评价与Meta分析
- Title En
- Rate of adherence, side effects and clinical outcomes of endocrine therapies among women with non-metastatic breast cancer in developing countries: a systematic review and meta-analysis
- Bilingual Status
- complete